PMH25 COST-EFFECTIVENESS OF ESCITALOPRAM VERSUS VENLAFAXINE IN SECOND-LINE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) IN SWEDEN
May 1, 2009, 00:00
10.1016/S1098-3015(10)73946-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)73946-2/fulltext
Title :
PMH25 COST-EFFECTIVENESS OF ESCITALOPRAM VERSUS VENLAFAXINE IN SECOND-LINE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) IN SWEDEN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73946-2&doi=10.1016/S1098-3015(10)73946-2
First page :
Section Title :
Open access? :
No
Section Order :
429